Shares of Vanda Pharmaceuticals Down 6% Premarket as Co Rejects Future Pak and Cycle Pharma's Takeover Offers
萬達生物製藥股票在盤前下跌6%,因該公司拒絕了未來派克和環球藥業的收購要約。
Shares of Vanda Pharmaceuticals Down 6% Premarket as Co Rejects Future Pak and Cycle Pharma's Takeover Offers
萬達生物製藥股票在盤前下跌6%,因該公司拒絕了未來派克和環球藥業的收購要約。
譯文內容由第三人軟體翻譯。